Idiopathic opsoclonus myoclonus ataxia syndrome: Apresentação de um paciente pediátrico

Descripción del Articulo

Objective. Report a case of opsoclonus-myoclonus-ataxic syndrome or Kirnsbourne syndrome, due to its infrequent presentation, with an estimated incidence of around 1/5 000 000, 50 % or more of paraneoplastic etiology and a very limited number not described in the literature on idiopathic etiology, i...

Descripción completa

Detalles Bibliográficos
Autores: Suclla Velásquez, Lutgarda Laura, Lazo Rivera, Edwin
Formato: artículo
Fecha de Publicación:2023
Institución:Universidad de Huánuco
Repositorio:Revistas - Universidad de Huánuco
Lenguaje:español
OAI Identifier:oai:ojs2.localhost:article/322
Enlace del recurso:http://revistas.udh.edu.pe/index.php/RPCS/article/view/392e
Nivel de acceso:acceso abierto
Materia:ataxia
opsoclonus
mioclonus
kinsbourne
opsoclonia
mioclonia
myoclonus
Descripción
Sumario:Objective. Report a case of opsoclonus-myoclonus-ataxic syndrome or Kirnsbourne syndrome, due to its infrequent presentation, with an estimated incidence of around 1/5 000 000, 50 % or more of paraneoplastic etiology and a very limited number not described in the literature on idiopathic etiology, in addition to the fact that 70 to 80 % of patients suffering from said syndrome present subsequent neurological sequelae. Clinical case summary. We present the case of a 7-year-old girl with ataxia, myoclonus and opsoclonus of idiopathic origin, who received treatment with pulsed methylprednisolone and immunoglobulin, followed by the use of oral corticosteroids for the following months. Finally, she presented an almost complete recovery two months after starting the treatment. Conclusions. Opsoclono-myoclono-ataxic syndrome is a rare neurological disorder in pediatrics in which the presence of associated tumors must first be ruled out, among them the most important neuroblastoma and take into account that although it can be limited to only 4 months of time of disease, the mainstay of its treatment is the use of high doses of corticosteroids to prevent it from worsening as well as the appearance of possible neurological sequelae in the future.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).